A chain of events possibly triggered by unrecognized infection with the SARS-CoV-2 coronavirus could be causing the mysterious cases of severe hepatitis reported in hundreds of young children around the world, researchers suggest.
RedHill pill shows promise vs Omicron; mRNA vaccines appear effective in those with well-controlled HIVAntibiotics, Antiretroviral Therapy, BNT162b2 (Pfizer and BioNTech), Coronavirus Vaccines, COVID-19 Studies, COVID-19 treatment pill, Gilead, HIV, Hospitalized COVID-19 Patients, JAMA, Messenger RNA (mRNA) Vaccines, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Omicron (B.1.1.529) (South Africa), R&D, Remdesivir, Steroids
An experimental drug being developed by RedHill Biopharma Ltd. that improved outcomes in a randomized trial involving severely ill COVID-19 patients infected with earlier versions of the coronavirus is showing promise against the Omicron variant in test tube experiments, researchers said. Additionally, people living with well-controlled HIV infections are likely to have immune responses to the mRNA COVID-19 vaccines from Moderna and from Pfizer/BioNTech similar to those of otherwise healthy individuals, according to new data.
Some immune system memory persists year after infection; COVID from Omicron also less severe for pregnant womenAntibodies, China, Coronavirus Infections, COVID-19 Studies, COVID-19 Vaccinations, Doctors, Immune System, JAMA, Omicron (B.1.1.529) (South Africa), Omicron BA.2, Pregnancies, R&D, Texas, The Lancet Microbe, Women
A year after infection with the coronavirus – when antibodies in the blood are barely detectable – the immune system continues to “remember” the virus and should respond to some extent upon re-encountering it, a study from China suggests. According to new research, women who were pregnant during the recent Omicron surge had more than eight times the rate of COVID-19 diagnoses, but lower odds of severe illness compared with pregnant women diagnosed earlier in the pandemic.
Pfizer Boss Earned $24.3 Million in 2021 and Other COVID-19 NewsAstraZeneca, Business, Coronavirus Disease (COVID-19) Pandemic, COVID-19 cases, COVID-19 Vaccinations, Dr. Anthony Fauci (Director), Hospitalized COVID-19 Patients, JAMA, Johns Hopkins University School of Medicine, Omicron BA.2, Pfizer, R&D, Researchers, Salaries, Tinnitus
Pfizer CEO Albert Bourla raked in $24.3 million in total compensation in 2021. In other news, tinnitus (ringing or buzzing in one or both ears) might be a side effect of COVID-19 vaccines.
Lilly and Roche expressed their criticism of the draft guidance from the U.S. Centers for Medicare & Medicaid Services (CMS) for Biogen’s Alzheimer’s drug Aduhelm (aducanumab).
COVID Update: Pill Production Underway and Vaccines in Pregnant WomenAnimals, Antivirals, Babies, COVID-19 Vaccinations, CVS Health, Infusion Therapy, JAMA, Long COVID, Massachusetts General Hospital, Merck, Molnupiravir, National Institutes of Health, Paxlovid, Pfizer, Pharmacies, Pills, Pregnancies, R&D, Remdesivir, Retail Pharmacies, SARS-CoV-2 virus, Therapeutics
Merck & Co. and Ridgeback Biotherapeutics announced they have supplied about 3.1 million courses of their antiviral drug against COVID-19, molnupiravir, to the U.S. government. In other news, a study funded by the National Institutes of Health found that vaccination against COVID-19 not only protects pregnant women against the disease but their babies as well.
Many babies of mRNA-vaccinated moms have antibodies at 6 months; Moderate COVID tied to higher childbirth risksBirth, Covid-19 Data, COVID-19 Infections, COVID-19 Studies, Eli Lilly, Infants, JAMA, Monoclonal Antibodies, Mothers, Pregnancies, R&D, Regeneron Pharmaceuticals, Severe Covid-19, United States
At 6 months of age, babies born to mothers vaccinated against COVID-19 during pregnancy are more likely to have antibodies against the virus in their blood than babies born to unvaccinated mothers who were infected while pregnant, a small study suggests. Additionally, contracting COVID-19 late in pregnancy is linked with a higher risk for obstetric complications, new data suggest.
Pfizer, Moderna shots safe during in vitro fertilization; healthy gut bacteria may help prevent long COVIDBacteria, BNT162b2 (Pfizer and BioNTech), Clinical Trials, COVID-19 cases, COVID-19 Studies, COVID-19 Test Kits, COVID-19 Vaccinations, COVID-19 Vaccines, Covid-19 Variants, Gut microbes, In-Vitro Fertilization, JAMA, Long COVID, Microbiome, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Myocarditis, Portable PCR COVID-19 Test Kits, R&D, SARS-CoV-2 virus, Small Intestine
COVID-19 vaccines using mRNA technology do not affect fertility outcomes during in-vitro fertilization (IVF), researchers found. Other new findings suggest the bacteria living in the small intestine may contribute to the risk for long COVID after infection with SARS-CoV-2.
About 35% of People Who Received Placebo in Vaccine Trials Report Side Effects and More COVID-19 NewsAdverse Events, BNT162b2 (Pfizer and BioNTech), Business, CDC, Clinical Trials, COVID-19 Antibodies, COVID-19 forecasts, COVID-19 Studies, COVID-19 Vaccines, Harvard Medical School, Intensive Care Units (ICUs), JAMA, Janssen COVID-19 Vaccine (J&J), Johnson & Johnson, Long COVID, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Nature Communications, Omicron (B.1.1.529) (South Africa), Placebo, R&D, Side Effects, The Netherlands
According to a recent study conducted by researchers at Harvard Medical School and Beth Israel Deaconess Medical Center, 76 percent of the adverse side effects (such as fatigue or headache) that people experienced after receiving their first COVID-19 vaccination were also reported by participants who received a placebo shot.
U.S. studies highlight the need for COVID boosters to fight OmicronBNT162b2 (Pfizer and BioNTech), CDC, COVID-19 booster shots, COVID-19 cases, Covid-19 Data, COVID-19 shots, COVID-19 Studies, COVID-19 Vaccines, JAMA, Messenger RNA (mRNA) Vaccines, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Omicron (B.1.1.529) (South Africa), United States
Three U.S. studies show that a third dose of an mRNA vaccine is key to fighting the Omicron coronavirus variant, providing 90% protection against hospitalization due to COVID-19, the U.S. Centers for Disease Control and Prevention (CDC) said on January 21.